Kelly K. Hunt, MD, on Breast Cancer and Neoadjuvant Therapy: Expert Commentary

April 30, 2024 By The ASCO Post Staff

Kelly K. Hunt, MD, of The University of Texas MD Anderson Cancer Center, discusses the benefits to patients with neoadjuvant therapy in advanced, inoperable breast cancer, for whom this treatment works best, and novel approaches currently under investigation.

Related Content